Icosagen Cell Factory (CRDMO)

Icosagen Cell Factory (ICF) is the research & development service arm of Icosagen Group, established in 2005. Since then, ICF has organically grown into a mammalian Contract Research, Development and Manufacturing Organization (CRDMO) for the biopharmaceutical, biotechnology, and diagnostic industry. Our clients turn to us for custom-tailored services from discovery, hit-to-lead finding, pre-clinical candidate selection and up to early clinical candidate development. This entails antibody and protein discovery, including complicated proteins, their multi-parallel recombinant production (CHO & HEK), up to stable CHO cell line development and large scale GMP manufacturing on site. By spanning the entire discovery, pre-clinical and early clinical development path, our clients save time, funds, and nerves. Lengthy and error-prone tech transfers are avoided, while molecule know-how remains in house, and legal agreements & project teams in place. These integrated, semi-parallel development capabilities enable greatly accelerated development times. We are known to be scientifically knowledgeable, technically savvy, and meticulous, as well as quick and responsive. Our credo is quality, provided rapidly and economically. In 2021, Icosagen Cell Factory worked with 157 protein drug or vaccine developing companies globally, in 562 projects, producing more than 1500 different proteins.